Varian Medical Systems, Inc. (VAR) SVP John W. Kuo Sells 863 Shares
Varian Medical Systems, Inc. (NYSE:VAR) SVP John W. Kuo sold 863 shares of the company’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $108.43, for a total value of $93,575.09. Following the completion of the transaction, the senior vice president now owns 28,224 shares in the company, valued at approximately $3,060,328.32. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Shares of Varian Medical Systems, Inc. (NYSE:VAR) opened at $110.32 on Friday. The company has a market capitalization of $10,038.47, a P/E ratio of 41.01, a P/E/G ratio of 3.33 and a beta of 0.67. Varian Medical Systems, Inc. has a 12 month low of $75.54 and a 12 month high of $114.09.
Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.19 by ($0.10). The firm had revenue of $739.00 million during the quarter, compared to the consensus estimate of $741.69 million. Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The company’s quarterly revenue was down 1.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.03 EPS. equities analysts anticipate that Varian Medical Systems, Inc. will post 4.11 earnings per share for the current year.
A number of equities analysts have recently weighed in on the company. Royal Bank of Canada set a $105.00 target price on Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, November 30th. BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a report on Sunday, October 29th. Evercore ISI assumed coverage on Varian Medical Systems in a report on Wednesday, January 3rd. They issued an “underperform” rating and a $100.00 target price on the stock. Citigroup upped their target price on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a report on Monday, October 30th. Finally, Zacks Investment Research downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Friday, October 27th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company’s stock. Varian Medical Systems currently has an average rating of “Hold” and a consensus target price of $100.44.
About Varian Medical Systems
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.